KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Cash from Financing Activities (2021 - 2025)

QuidelOrtho's Cash from Financing Activities history spans 5 years, with the latest figure at -$11.1 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 83.89% year-over-year to -$11.1 million; the TTM value through Dec 2025 reached $155.8 million, up 219.26%, while the annual FY2025 figure was $155.8 million, 219.26% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$11.1 million at QuidelOrtho, down from $46.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $424.2 million in Q1 2023 and bottomed at -$99.7 million in Q3 2023.
  • The 5-year median for Cash from Financing Activities is -$11.1 million (2025), against an average of $24.1 million.
  • The largest annual shift saw Cash from Financing Activities crashed 1652.94% in 2023 before it surged 274.9% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $1.8 million in 2021, then tumbled by 288.89% to -$3.4 million in 2022, then crashed by 1600.0% to -$57.8 million in 2023, then decreased by 19.2% to -$68.9 million in 2024, then soared by 83.89% to -$11.1 million in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Cash from Financing Activities are -$11.1 million (Q4 2025), $46.0 million (Q3 2025), and $103.3 million (Q2 2025).